Is Aclaris Therapeutics, Inc. (ACRS) a Buy, Sell, or Hold?
NASDAQ : ACRS
Aclaris Therapeutics, Inc.
$5.515 USD
$0.15 (2.89%)
- Volume
- 6.08M
- Average Volume
- 1.67M
- Market Capitalization
- $665.08M
- P/E Ratio
- -10.00
- Dividend Yield
- 0.00%
- Price Target
- $10.00
- Year High
- $5.85
- Year Low
- $1.46
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.03
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
52
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
38
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$595.74K
ACRS Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
ACRS Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Mehra Anand | director | 2026-06-05 | M-Exempt | 0 | 2026-06-08 |
| SCHIFF ANDREW N | director | 2026-06-04 | A-Award | 4.71 | 2026-06-08 |
| Mehra Anand | director | 2026-06-04 | A-Award | 4.71 | 2026-06-08 |
| SCHIFF ANDREW N | director | 2026-06-05 | M-Exempt | 0 | 2026-06-08 |
| SCHIFF ANDREW N | director | 2026-06-04 | A-Award | 0 | 2026-06-08 |
| Mehra Anand | director | 2026-06-04 | A-Award | 0 | 2026-06-08 |
| Mehra Anand | director | 2026-06-05 | M-Exempt | 0 | 2026-06-08 |
| SCHIFF ANDREW N | director | 2026-06-05 | M-Exempt | 0 | 2026-06-08 |
| Molineaux Christopher P. | director | 2026-06-05 | M-Exempt | 0 | 2026-06-08 |
| Humphries William D. | director | 2026-06-05 | M-Exempt | 0 | 2026-06-08 |
| Molineaux Christopher P. | director | 2026-06-04 | A-Award | 4.71 | 2026-06-08 |
| Humphries William D. | director | 2026-06-04 | A-Award | 4.71 | 2026-06-08 |
| Humphries William D. | director | 2026-06-04 | A-Award | 0 | 2026-06-08 |
| Molineaux Christopher P. | director | 2026-06-04 | A-Award | 0 | 2026-06-08 |
| Molineaux Christopher P. | director | 2026-06-05 | M-Exempt | 0 | 2026-06-08 |
| Humphries William D. | director | 2026-06-05 | M-Exempt | 0 | 2026-06-08 |
| MILANO VINCENT | director | 2026-06-04 | A-Award | 4.71 | 2026-06-08 |
| MILANO VINCENT | director | 2026-06-05 | M-Exempt | 0 | 2026-06-08 |
| MILANO VINCENT | director | 2026-06-04 | A-Award | 0 | 2026-06-08 |
| MILANO VINCENT | director | 2026-06-05 | M-Exempt | 0 | 2026-06-08 |
| GOWEN MAXINE | director | 2026-06-04 | A-Award | 4.71 | 2026-06-08 |
| GOWEN MAXINE | director | 2026-06-05 | M-Exempt | 0 | 2026-06-08 |
| GOWEN MAXINE | director | 2026-06-04 | A-Award | 0 | 2026-06-08 |
| GOWEN MAXINE | director | 2026-06-05 | M-Exempt | 0 | 2026-06-08 |
| Hall Jesse Wayne | officer: Chief Medical Officer | 2026-05-01 | M-Exempt | 0 | 2026-05-05 |
| Hall Jesse Wayne | officer: Chief Medical Officer | 2026-05-01 | M-Exempt | 0 | 2026-05-05 |
| Hall Jesse Wayne | officer: Chief Medical Officer | 2026-05-01 | F-InKind | 4.41 | 2026-05-05 |
| Leonard Braden Michael | 10 percent owner | 2026-04-23 | S-Sale | 4.53 | 2026-04-27 |
| Balthaser Kevin | officer: Chief Financial Officer | 2026-03-01 | M-Exempt | 0 | 2026-03-03 |
| Balthaser Kevin | officer: Chief Financial Officer | 2026-03-01 | F-InKind | 2.87 | 2026-03-03 |
| Balthaser Kevin | officer: Chief Financial Officer | 2026-03-01 | M-Exempt | 0 | 2026-03-03 |
| Walker Neal | director, officer: CEO | 2026-02-02 | A-Award | 3.61 | 2026-02-06 |
| Walker Neal | director, officer: CEO | 2026-02-02 | A-Award | 0 | 2026-02-06 |
| Davis Hugh M. | director, officer: President and COO | 2026-02-02 | A-Award | 3.61 | 2026-02-06 |
| Davis Hugh M. | director, officer: President and COO | 2026-02-02 | A-Award | 0 | 2026-02-06 |
| Kolbeck Roland Wilhelm | officer: Chief Scientific Officer | 2026-02-02 | A-Award | 3.61 | 2026-02-06 |
| Kolbeck Roland Wilhelm | officer: Chief Scientific Officer | 2026-02-02 | A-Award | 0 | 2026-02-06 |
| Hall Jesse Wayne | officer: Chief Medical Officer | 2026-02-02 | A-Award | 3.61 | 2026-02-06 |
| Hall Jesse Wayne | officer: Chief Medical Officer | 2026-02-02 | A-Award | 0 | 2026-02-06 |
| Loerop James | officer: Chief Business Officer | 2026-02-02 | A-Award | 3.61 | 2026-02-06 |
| Loerop James | officer: Chief Business Officer | 2026-02-02 | A-Award | 0 | 2026-02-06 |
| Balthaser Kevin | officer: Chief Financial Officer | 2026-02-02 | A-Award | 3.61 | 2026-02-06 |
| Balthaser Kevin | officer: Chief Financial Officer | 2026-02-02 | A-Award | 0 | 2026-02-06 |
| Loerop James | officer: Chief Business Officer | 2026-02-03 | M-Exempt | 0 | 2026-02-05 |
| Loerop James | officer: Chief Business Officer | 2026-02-03 | F-InKind | 3.47 | 2026-02-05 |
| Loerop James | officer: Chief Business Officer | 2026-02-03 | M-Exempt | 0 | 2026-02-05 |
| Walker Neal | director, officer: CEO | 2026-02-03 | M-Exempt | 0 | 2026-02-05 |
| Walker Neal | director, officer: CEO | 2026-02-03 | F-InKind | 3.47 | 2026-02-05 |
| Walker Neal | director, officer: CEO | 2026-02-03 | M-Exempt | 0 | 2026-02-05 |
| Davis Hugh M. | director, officer: President and COO | 2026-02-03 | M-Exempt | 0 | 2026-02-05 |
| Davis Hugh M. | director, officer: President and COO | 2026-02-03 | M-Exempt | 0 | 2026-02-05 |
| Balthaser Kevin | officer: Chief Financial Officer | 2026-02-03 | M-Exempt | 0 | 2026-02-05 |
| Balthaser Kevin | officer: Chief Financial Officer | 2026-02-03 | F-InKind | 3.47 | 2026-02-05 |
| Balthaser Kevin | officer: Chief Financial Officer | 2026-02-03 | M-Exempt | 0 | 2026-02-05 |
| Loerop James | officer: Chief Business Officer | 2026-02-01 | M-Exempt | 0 | 2026-02-05 |
| Loerop James | officer: Chief Business Officer | 2026-02-01 | F-InKind | 3.51 | 2026-02-05 |
| Loerop James | officer: Chief Business Officer | 2026-02-01 | M-Exempt | 0 | 2026-02-05 |
| Loerop James | officer: Chief Business Officer | 2026-02-01 | M-Exempt | 0 | 2026-02-05 |
| Loerop James | officer: Chief Business Officer | 2026-02-01 | M-Exempt | 0 | 2026-02-05 |
| Loerop James | officer: Chief Business Officer | 2026-02-01 | M-Exempt | 0 | 2026-02-05 |
| Loerop James | officer: Chief Business Officer | 2026-02-01 | M-Exempt | 0 | 2026-02-05 |
| Balthaser Kevin | officer: Chief Financial Officer | 2026-02-01 | M-Exempt | 0 | 2026-02-03 |
| Balthaser Kevin | officer: Chief Financial Officer | 2026-02-01 | F-InKind | 3.51 | 2026-02-03 |
| Balthaser Kevin | officer: Chief Financial Officer | 2026-02-01 | M-Exempt | 0 | 2026-02-03 |
| Loerop James | officer: Chief Business Officer | 2025-02-01 | F-InKind | 2.48 | 2026-02-03 |
| Walker Neal | director, officer: CEO | 2026-01-02 | M-Exempt | 0 | 2026-01-05 |
| Walker Neal | director, officer: CEO | 2026-01-02 | F-InKind | 2.88 | 2026-01-05 |
| Walker Neal | director, officer: CEO | 2026-01-02 | M-Exempt | 0 | 2026-01-05 |
| Loerop James | officer: Chief Business Officer | 2025-12-31 | M-Exempt | 0 | 2026-01-05 |
| Loerop James | officer: Chief Business Officer | 2026-01-02 | M-Exempt | 0 | 2026-01-05 |
| Loerop James | officer: Chief Business Officer | 2026-01-02 | F-InKind | 2.88 | 2026-01-05 |
| Loerop James | officer: Chief Business Officer | 2025-12-31 | F-InKind | 3.01 | 2026-01-05 |
| Loerop James | officer: Chief Business Officer | 2026-01-02 | M-Exempt | 0 | 2026-01-05 |
| Loerop James | officer: Chief Business Officer | 2025-12-31 | M-Exempt | 0 | 2026-01-05 |
| Balthaser Kevin | officer: Chief Financial Officer | 2025-12-31 | M-Exempt | 0 | 2026-01-05 |
| Balthaser Kevin | officer: Chief Financial Officer | 2026-01-02 | M-Exempt | 0 | 2026-01-05 |
| Balthaser Kevin | officer: Chief Financial Officer | 2026-01-02 | F-InKind | 2.88 | 2026-01-05 |
| Balthaser Kevin | officer: Chief Financial Officer | 2026-01-01 | M-Exempt | 0 | 2026-01-05 |
| Balthaser Kevin | officer: Chief Financial Officer | 2026-01-01 | F-InKind | 3.01 | 2026-01-05 |
| Balthaser Kevin | officer: Chief Financial Officer | 2025-12-31 | F-InKind | 3.01 | 2026-01-05 |
| Balthaser Kevin | officer: Chief Financial Officer | 2026-01-02 | M-Exempt | 0 | 2026-01-05 |
| Balthaser Kevin | officer: Chief Financial Officer | 2026-01-01 | M-Exempt | 0 | 2026-01-05 |
| Balthaser Kevin | officer: Chief Financial Officer | 2025-12-31 | M-Exempt | 0 | 2026-01-05 |
| Davis Hugh M. | director, officer: President and COO | 2025-12-02 | M-Exempt | 0 | 2025-12-04 |
| Davis Hugh M. | director, officer: President and COO | 2025-12-02 | M-Exempt | 0 | 2025-12-04 |
| Kolbeck Roland Wilhelm | officer: Chief Scientific Officer | 2025-08-01 | A-Award | 1.53 | 2025-08-05 |
| Kolbeck Roland Wilhelm | officer: Chief Scientific Officer | 2025-08-01 | A-Award | 0 | 2025-08-05 |
| Kolbeck Roland Wilhelm | 2025-07-28 | 0 | 2025-08-05 | ||
| SCHIFF ANDREW N | director | 2025-06-05 | A-Award | 1.56 | 2025-06-09 |
| SCHIFF ANDREW N | director | 2025-06-06 | M-Exempt | 0 | 2025-06-09 |
| SCHIFF ANDREW N | director | 2025-06-05 | A-Award | 0 | 2025-06-09 |
| SCHIFF ANDREW N | director | 2025-06-06 | M-Exempt | 0 | 2025-06-09 |
| MILANO VINCENT | director | 2025-06-05 | A-Award | 1.56 | 2025-06-09 |
| MILANO VINCENT | director | 2025-06-06 | M-Exempt | 0 | 2025-06-09 |
| MILANO VINCENT | director | 2025-06-05 | A-Award | 0 | 2025-06-09 |
| MILANO VINCENT | director | 2025-06-06 | M-Exempt | 0 | 2025-06-09 |
| Mehra Anand | director | 2025-06-06 | M-Exempt | 0 | 2025-06-09 |
| Mehra Anand | director | 2025-06-05 | A-Award | 1.56 | 2025-06-09 |
| Mehra Anand | director | 2025-06-05 | A-Award | 0 | 2025-06-09 |
| Mehra Anand | director | 2025-06-06 | M-Exempt | 0 | 2025-06-09 |